|
|
Volumn 4, Issue 1, 1996, Pages 61-70
|
|
Differential inhibition of cyclooxygenase-1 (COX-1) and -2 (COX-2) by NSAIDs: Consequences on anti-inflammatory activity versus gastric and renal safety
|
|
Author keywords
COX 1; COX 2; NSAIDs
|
|
Indexed keywords
4 (3,5 DI TERT BUTYL 4 HYDROXYPHENYL) 2 METHYL 1,2 OXAZIN 3 ONE;
5 (4 FLUOROPHENYL) 1 [(4 METHYLSULFONYL)PHENYL] 3 TRIFLUOROMETHYLPYRAZOLE;
5 BROMO 2 (4 FLUOROPHENYL) 3 (4 METHYLSULFONYLPHENYL)THIOPHENE;
6 (2,4 DIFLUOROPHENYLTHIO) 5 METHANESULFONAMIDO 1 INDANONE;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 2;
DICLOFENAC;
FLOSULIDE;
GLUCOCORTICOID;
IBUPROFEN;
IGURATIMOD;
INDOMETACIN;
ISOENZYME;
MELOXICAM;
N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE;
NAPROXEN;
NONSTEROID ANTIINFLAMMATORY AGENT;
PIROXICAM;
PROSTAGLANDIN SYNTHASE INHIBITOR;
ANIMAL MODEL;
ANTIINFLAMMATORY ACTIVITY;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG SAFETY;
GASTROINTESTINAL TOXICITY;
HUMAN;
INFLAMMATION;
NEPHROTOXICITY;
NONHUMAN;
PRIORITY JOURNAL;
RHEUMATIC DISEASE;
|
|
EID: 0029879078
PISSN: 09254692
EISSN: None
Source Type: Journal
DOI: 10.1007/BF02735560 Document Type: Conference Paper |
|
Times cited : (18)
|
|
References (0)
|
